Please login to the form below

Not currently logged in
Email:
Password:

U300

This page shows the latest U300 news and features for those working in and with pharma, biotech and healthcare.

Lilly signs $570m deal for next-gen Humalog

Lilly signs $570m deal for next-gen Humalog

Meanwhile, a BioChaperone version of the U200 formulation is also in the pipeline, along with an even higher (U300) dose, according to Adocia and Lilly.

Latest news

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics